| __timestamp | Insmed Incorporated | Travere Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 31073000 | 59644696 |
| Thursday, January 1, 2015 | 43216000 | 79541000 |
| Friday, January 1, 2016 | 50679000 | 98015000 |
| Sunday, January 1, 2017 | 79171000 | 103958000 |
| Monday, January 1, 2018 | 168218000 | 103654000 |
| Tuesday, January 1, 2019 | 210796000 | 128951000 |
| Wednesday, January 1, 2020 | 203613000 | 135799000 |
| Friday, January 1, 2021 | 234273000 | 149883000 |
| Saturday, January 1, 2022 | 265784000 | 220206000 |
| Sunday, January 1, 2023 | 344501000 | 265542000 |
Unleashing insights
In the competitive world of biotechnology, managing Selling, General, and Administrative (SG&A) expenses is crucial for financial health. Over the past decade, Insmed Incorporated and Travere Therapeutics, Inc. have shown distinct strategies in optimizing these costs. From 2014 to 2023, Insmed's SG&A expenses surged by over 1,000%, peaking at $344 million in 2023. In contrast, Travere's expenses grew by approximately 345%, reaching $266 million in the same year.
While both companies have seen significant increases, Insmed's rapid growth in SG&A expenses suggests aggressive expansion or investment in administrative capabilities. Meanwhile, Travere's steadier increase may indicate a more controlled approach. Understanding these trends provides valuable insights into each company's operational strategies and financial priorities. As the biotech industry continues to evolve, monitoring SG&A expenses will remain a key indicator of a company's efficiency and strategic direction.
Who Optimizes SG&A Costs Better? Summit Therapeutics Inc. or Insmed Incorporated
Who Optimizes SG&A Costs Better? Insmed Incorporated or Catalent, Inc.
Operational Costs Compared: SG&A Analysis of Insmed Incorporated and Dr. Reddy's Laboratories Limited
Selling, General, and Administrative Costs: Insmed Incorporated vs CymaBay Therapeutics, Inc.
Comparing SG&A Expenses: Insmed Incorporated vs HUTCHMED (China) Limited Trends and Insights
Who Optimizes SG&A Costs Better? Insmed Incorporated or Wave Life Sciences Ltd.
Operational Costs Compared: SG&A Analysis of Insmed Incorporated and Evotec SE
SG&A Efficiency Analysis: Comparing Corcept Therapeutics Incorporated and Travere Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Ionis Pharmaceuticals, Inc. and Travere Therapeutics, Inc.
Selling, General, and Administrative Costs: Verona Pharma plc vs Travere Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Mesoblast Limited and Travere Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Amphastar Pharmaceuticals, Inc. and Travere Therapeutics, Inc.